Why the study?
Does low molecular weight heparin Kabi 2165 prevent deep vein thrombosis in patients undergoing general surgery compared to standard heparin?
Does low molecular weight heparin Kabi 2165 prevent deep vein thrombosis in patients undergoing general surgery compared to standard heparin?
Answers are grounded in this paper and cite their sources.
LMWH Kabi 2165 once daily matches standard heparin twice daily for DVT prevention with comparable bleeding; extends evidence for convenient once-daily LMWH prophylaxis in general surgery.
No AccessJournal of Urology1 Apr 1989A Randomized Double-Blind Study Between a Low Molecular Weight Heparin Kabi 2165 and Standard Heparin in the Prevention of Deep Vein Thrombosis in General Surgery: A French Multicenter Trial J.P. Caen J.P. CaenJ.P. Caen More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)41145-1AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "A Randomized Double-Blind Study Between a Low Molecular Weight Heparin Kabi 2165 and Standard Heparin in the Prevention of Deep Vein Thrombosis in General Surgery: A French Multicenter Trial." The Journal of Urology, 141(4), pp. 1052–1053 © 1989 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 141Issue 4April 1989Page: 1052-1053 Advertisement Copyright & Permissions© 1989 by The American Urological Association Education and Research, Inc.MetricsAuthor Information J.P. Caen More articles by this author Expand All Advertisement Loading ...
No takes yet. Share an insight, caveat, or question.
Jacques Caen (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: